 |
|
Identification and Characterization of Metabolically Benign Obesity in Humans
Norbert Stefan, MD;
Konstantinos Kantartzis, MD;
Jürgen Machann, PhD;
Fritz Schick, PhD;
Claus Thamer, MD;
Kilian Rittig, MD;
Bernd Balletshofer, MD;
Fausto Machicao, PhD;
Andreas Fritsche, MD;
Hans-Ulrich Häring, MD
Arch Intern Med. 2008;168(15):1609-1616.
Background Obesity represents a risk factor for insulin resistance, type 2 diabetes mellitus, and atherosclerosis. In addition, for any given amount of total body fat, an excess of visceral fat or fat accumulation in the liver and skeletal muscle augments the risk. Conversely, even in obesity, a metabolically benign fat distribution phenotype may exist.
Methods In 314 subjects, we measured total body, visceral, and subcutaneous fat with magnetic resonance (MR) tomography and fat in the liver and skeletal muscle with proton MR spectroscopy. Insulin sensitivity was estimated from oral glucose tolerance test results. Subjects were divided into 4 groups: normal weight (body mass index [BMI] [calculated as weight in kilograms divided by height in meters squared], <25.0), overweight (BMI, 25.0-29.9), obese–insulin sensitive (IS) (BMI,  30.0 and placement in the upper quartile of insulin sensitivity), and obese–insulin resistant (IR) (BMI, 30.0 and placement in the lower 3 quartiles of insulin sensitivity).
Results Total body and visceral fat were higher in the overweight and obese groups compared with the normal-weight group (P < .05); however, no differences were observed between the obese groups. In contrast, ectopic fat in skeletal muscle (P < .001) and particularly the liver (4.3% ± 0.6% vs 9.5% ± 0.8%) and the intima-media thickness of the common carotid artery (0.54 ± 0.02 vs 0.59 ± 0.01 mm) were lower and insulin sensitivity was higher (17.4 ± 0.9 vs 7.3 ± 0.3 arbitrary units) in the obese-IS vs the obese-IR group (P < .05). Unexpectedly, the obese-IS group had almost identical insulin sensitivity and the intima-media thickness was not statistically different compared with the normal-weight group (18.2 ± 0.9 AU and 0.51 ± 0.02 mm, respectively).
Conclusions A metabolically benign obesity that is not accompanied by insulin resistance and early atherosclerosis exists in humans. Furthermore, ectopic fat in the liver may be more important than visceral fat in the determination of such a beneficial phenotype in obesity.
Author Affiliations: Department of Internal Medicine IV (Drs Stefan, Kantartzis, Thamer, Rittig, Balletshofer, Machicao, Fritsche, and Häring) and Section on Experimental Radiology (Drs Machann and Schick), University of Tübingen, Tübingen, Germany.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
RELATED ARTICLES
In This Issue of Archives of Internal Medicine
Arch Intern Med. 2008;168(15):1604.
FULL TEXT
Body Fat Distribution and Cardiovascular Risk: A Tale of 2 Sites
Lewis Landsberg
Arch Intern Med. 2008;168(15):1607-1608.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Orange Juice vs Soft Drinks
Alcada et al.
Arch Intern Med 2009;169:315-315.
FULL TEXT
Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at?
Zhao et al.
Am. J. Physiol. Endocrinol. Metab. 2009;296:E384-E393.
ABSTRACT
| FULL TEXT
The Metabolic Syndrome
Cornier et al.
Endocr. Rev. 2008;29:777-822.
ABSTRACT
| FULL TEXT
How Fat Am I? Or, How Am I Fat?
Journal Watch Cardiology 2008;2008:3-3.
FULL TEXT
Body Fat Distribution and Cardiovascular Risk: A Tale of 2 Sites
Landsberg
Arch Intern Med 2008;168:1607-1608.
FULL TEXT
|
